Skip to main content
Top
Gepubliceerd in:

26-04-2017 | Original Paper

Assessing the Dim Light Melatonin Onset in Adults with Autism Spectrum Disorder and No Comorbid Intellectual Disability

Auteurs: Emma K. Baker, Amanda L. Richdale, Agnes Hazi, Luke A. Prendergast

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 7/2017

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

This study assessed melatonin levels and the dim light melatonin onset (DLMO) in adults with Autism Spectrum Disorder (ASD) and also investigated the relationships between melatonin and objectively measured sleep parameters. Sixteen adults with ASD (ASD-Only), 12 adults with ASD medicated for comorbid diagnoses of anxiety and/or depression (ASD-Med) and 32 controls participated in the study. Although, the timing of the DLMO did not differ between the two groups, advances and delays of the melatonin rhythm were observed in individual profiles. Overall mean melatonin levels were lower in the ASD-Med group compared to the two other groups. Lastly, greater increases in melatonin in the hour prior to sleep were associated with greater sleep efficiency in the ASD groups.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
go back to reference American Academy of Sleep Medicine (2014). International Classification of Sleep Disorders (3rd edn.). Darien, IL: American Academy of Sleep Medicine. American Academy of Sleep Medicine (2014). International Classification of Sleep Disorders (3rd edn.). Darien, IL: American Academy of Sleep Medicine.
go back to reference Arendt, J. (1995). Melatonin and the mammalian pineal gland (1st ed.). London: Chapman & Hall. Arendt, J. (1995). Melatonin and the mammalian pineal gland (1st ed.). London: Chapman & Hall.
go back to reference Baker, E. K., & Richdale, A. L. (2017). Examining the behavioural sleep–wake rhythm in adults with autism spectrum disorder and no comorbid intellectual disability. Journal of Autism and Developmental Disorders, 47, 1207–1222. doi:10.1007/s10803-017-3042-3.CrossRefPubMed Baker, E. K., & Richdale, A. L. (2017). Examining the behavioural sleep–wake rhythm in adults with autism spectrum disorder and no comorbid intellectual disability. Journal of Autism and Developmental Disorders, 47, 1207–1222. doi:10.​1007/​s10803-017-3042-3.CrossRefPubMed
go back to reference Baron-Cohen, S., Wheelwright, S., Skinner, R., Martin, J., & Clubley, E. (2001). The autism-spectrum quotient (AQ): Evidence from asperger syndrome/high-functioning autism, malesand females, scientists and mathematicians. Journal of Autism and Developmental Disorders, 31(1), 5–17. doi:10.1023/a:1005653411471.CrossRefPubMed Baron-Cohen, S., Wheelwright, S., Skinner, R., Martin, J., & Clubley, E. (2001). The autism-spectrum quotient (AQ): Evidence from asperger syndrome/high-functioning autism, malesand females, scientists and mathematicians. Journal of Autism and Developmental Disorders, 31(1), 5–17. doi:10.​1023/​a:​1005653411471.CrossRefPubMed
go back to reference Benloucif, S., Burgess, H. J., Klerman, E. B., Lewy, A. J., Middleton, B., Murphy, P. J., … Revell, V. L. (2008). Measuring melatonin in humans. Journal of Clinical Sleep Medicine, 4, 66–69.PubMedPubMedCentral Benloucif, S., Burgess, H. J., Klerman, E. B., Lewy, A. J., Middleton, B., Murphy, P. J., … Revell, V. L. (2008). Measuring melatonin in humans. Journal of Clinical Sleep Medicine, 4, 66–69.PubMedPubMedCentral
go back to reference Bootzin, R., Shoham, V., & Kuo, T. (1994). Sleep anticipatory anxiety questionnaire: A measure of anxiety about sleep. Sleep Research, 23, 188. Bootzin, R., Shoham, V., & Kuo, T. (1994). Sleep anticipatory anxiety questionnaire: A measure of anxiety about sleep. Sleep Research, 23, 188.
go back to reference Cohrs, S., Pohlmann, K., Guan, Z., Jordan, W., Meier, A., Huether, G., Rüther, E., & Rodenbeck, A. (2004). Quetiapine reduces nocturnal urinary cortisol excretion in healthy subjects. Psychopharmacology, 174, 414–420, doi:10.1007/s00213-003-1766-6.PubMed Cohrs, S., Pohlmann, K., Guan, Z., Jordan, W., Meier, A., Huether, G., Rüther, E., & Rodenbeck, A. (2004). Quetiapine reduces nocturnal urinary cortisol excretion in healthy subjects. Psychopharmacology, 174, 414–420, doi:10.​1007/​s00213-003-1766-6.PubMed
go back to reference Cortesi, F., Giannotti, F., Sebastiani, T., Panunzi, S., & Valente, D. (2012). Controlled-release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: a randomized placebo-controlled trial. Journal of Sleep Research, 21(6), 700–709, doi:10.1111/j.1365-2869.2012.01021.x.CrossRefPubMed Cortesi, F., Giannotti, F., Sebastiani, T., Panunzi, S., & Valente, D. (2012). Controlled-release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: a randomized placebo-controlled trial. Journal of Sleep Research, 21(6), 700–709, doi:10.​1111/​j.​1365-2869.​2012.​01021.​x.CrossRefPubMed
go back to reference Crowley, S. J. (2013). Assessment of Circadian Rhythms. In A. Wolfson & H. Montgomery-Downs (Eds.), The Oxford Handbook of Infant, Child, and Adolescent Sleep and Behavior. New York, NY: Oxford University Press. Crowley, S. J. (2013). Assessment of Circadian Rhythms. In A. Wolfson & H. Montgomery-Downs (Eds.), The Oxford Handbook of Infant, Child, and Adolescent Sleep and Behavior. New York, NY: Oxford University Press.
go back to reference Darcourt, G., Feuillade, P., Bistagnin, Y., Robert, P., Pringuey, D., Touari, M., Mrdji, Y., & Bensmaïl, B. (1995). Antidepressant effect of 5-methoxypsoralen: The melatonin synchronizer hypothesis. European Psychiatry, 10(3), 142–154. doi:10.1016/0767-399X(96)80103-9.CrossRefPubMed Darcourt, G., Feuillade, P., Bistagnin, Y., Robert, P., Pringuey, D., Touari, M., Mrdji, Y., & Bensmaïl, B. (1995). Antidepressant effect of 5-methoxypsoralen: The melatonin synchronizer hypothesis. European Psychiatry, 10(3), 142–154. doi:10.​1016/​0767-399X(96)80103-9.CrossRefPubMed
go back to reference Dijk, D. J., & Cajochen, C. (1997). Melatonin and the circadian regulation of sleep initiation, consolidation, structure, and the sleep EEG. Journal of Biological Rhythms, 12(6), 627–635.CrossRefPubMed Dijk, D. J., & Cajochen, C. (1997). Melatonin and the circadian regulation of sleep initiation, consolidation, structure, and the sleep EEG. Journal of Biological Rhythms, 12(6), 627–635.CrossRefPubMed
go back to reference Elrod, M. G., & Hood, B. S. (2015). Sleep differences among children with autism spectrum disorders and typically developing peers: A meta-analysis. Journal of Developmental and Behavioral Pediatrics, 36(3), 166–177.CrossRefPubMed Elrod, M. G., & Hood, B. S. (2015). Sleep differences among children with autism spectrum disorders and typically developing peers: A meta-analysis. Journal of Developmental and Behavioral Pediatrics, 36(3), 166–177.CrossRefPubMed
go back to reference Franklin, M., Clement, E. M., Campling, G., & Cowen, P. J. (1998). Effect of venlafaxine on pineal melatonin and noradrenaline in the male rat. Journal of Psychopharmacology, 12(4), 371–374.CrossRefPubMed Franklin, M., Clement, E. M., Campling, G., & Cowen, P. J. (1998). Effect of venlafaxine on pineal melatonin and noradrenaline in the male rat. Journal of Psychopharmacology, 12(4), 371–374.CrossRefPubMed
go back to reference Goldman, S. E., Adkins, K. W., Calcutt, M. W., Carter, M. D., Goodpaster, R. L., Wang, L., et al. (2014). Melatonin in children with autism spectrum disorders: endogenous and pharmacokinetic profiles in relation to sleep. Journal of Autism and Developmental Disorders, 44(10), 2525–2535. doi:10.1007/s10803-014-2123-9.CrossRefPubMedPubMedCentral Goldman, S. E., Adkins, K. W., Calcutt, M. W., Carter, M. D., Goodpaster, R. L., Wang, L., et al. (2014). Melatonin in children with autism spectrum disorders: endogenous and pharmacokinetic profiles in relation to sleep. Journal of Autism and Developmental Disorders, 44(10), 2525–2535. doi:10.​1007/​s10803-014-2123-9.CrossRefPubMedPubMedCentral
go back to reference Gotham, K., Brunwasser, S. M., & Lord, C. (2015). Depressive and anxiety symptom trajectories from school age through young adulthood in samples with autism spectrum disorder and developmental delay. Journal of the American Academy of Child & Adolescent Psychiatry, 54(5), 369–376.e363. doi:10.1016/j.jaac.2015.02.005.CrossRef Gotham, K., Brunwasser, S. M., & Lord, C. (2015). Depressive and anxiety symptom trajectories from school age through young adulthood in samples with autism spectrum disorder and developmental delay. Journal of the American Academy of Child & Adolescent Psychiatry, 54(5), 369–376.e363. doi:10.​1016/​j.​jaac.​2015.​02.​005.CrossRef
go back to reference Gringras, P., Gamble, C., Jones, A. P., Wiggs, L., Williamson, P. R., Sutcliffe, A., et al. (2012). Melatonin for sleep problems in children with neurodevelopmental disorders: Randomised double masked placebo controlled trial. BMJ (Clinical research ed.), 345, e6664. doi:10.1136/bmj.e6664.PubMedCentral Gringras, P., Gamble, C., Jones, A. P., Wiggs, L., Williamson, P. R., Sutcliffe, A., et al. (2012). Melatonin for sleep problems in children with neurodevelopmental disorders: Randomised double masked placebo controlled trial. BMJ (Clinical research ed.), 345, e6664. doi:10.​1136/​bmj.​e6664.PubMedCentral
go back to reference Guénolé, F., Godbout, R., Nicolas, A., Franco, P., Claustrat, B., & Baleyte, J.-M. (2011). Melatonin for disordered sleep in individuals with autism spectrum disorders: Systematic review and discussion. Sleep Medicine Reviews, 15(6), 379–387.CrossRefPubMed Guénolé, F., Godbout, R., Nicolas, A., Franco, P., Claustrat, B., & Baleyte, J.-M. (2011). Melatonin for disordered sleep in individuals with autism spectrum disorders: Systematic review and discussion. Sleep Medicine Reviews, 15(6), 379–387.CrossRefPubMed
go back to reference Hallam, K. T., Begg, D. P., Olver, J. S., & Norman, T. R. (2008). An investigation of the effect of immediate and extended release venlafaxine on nocturnal melatonin and cortisol release in healthy adult volunteers. Human Psychopharmacology: Clinical and Experimental, 23(2), 129–137. doi:10.1002/hup.913.CrossRef Hallam, K. T., Begg, D. P., Olver, J. S., & Norman, T. R. (2008). An investigation of the effect of immediate and extended release venlafaxine on nocturnal melatonin and cortisol release in healthy adult volunteers. Human Psychopharmacology: Clinical and Experimental, 23(2), 129–137. doi:10.​1002/​hup.​913.CrossRef
go back to reference Hare, D. J., Jones, S., & Evershed, K. (2006). A comparative study of circadian rhythm functioning and sleep in people with Asperger syndrome. Autism: The International Journal of Research and Practice, 10(6), 565–575. doi:10.1177/1362361306068509.CrossRef Hare, D. J., Jones, S., & Evershed, K. (2006). A comparative study of circadian rhythm functioning and sleep in people with Asperger syndrome. Autism: The International Journal of Research and Practice, 10(6), 565–575. doi:10.​1177/​1362361306068509​.CrossRef
go back to reference Hariharasubramanian, N., Nair, N. P., Pilapil, C., Isaac, I., & Quirion, R. (1986). Effect of imipramine on the circadian rhythm of plasma melatonin in unipolar depression. Chronobiology International, 3(1), 65–69.CrossRefPubMed Hariharasubramanian, N., Nair, N. P., Pilapil, C., Isaac, I., & Quirion, R. (1986). Effect of imipramine on the circadian rhythm of plasma melatonin in unipolar depression. Chronobiology International, 3(1), 65–69.CrossRefPubMed
go back to reference Härtter, S., Want, X., Weigmann, H., Friedberg, T., Arand, M., Oesch, F., & Hiemke, C. (2001). Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin. Journal of Clinical Psychopharmacology, 21(2), 167–174.CrossRefPubMed Härtter, S., Want, X., Weigmann, H., Friedberg, T., Arand, M., Oesch, F., & Hiemke, C. (2001). Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin. Journal of Clinical Psychopharmacology, 21(2), 167–174.CrossRefPubMed
go back to reference Hilli, J., Korhonen, T., Turpeinen, M., Hokkanen, J., Mattila, S., & Laine, K. (2008). The effect of oral contraceptives on the pharmacokinetics of melatonin in healthy subjects with CYP1A2 g.-163C > A polymorphism. Journal of Clinical Pharmacology, 48(8), 986–994. doi:10.1177/0091270008318669.CrossRefPubMed Hilli, J., Korhonen, T., Turpeinen, M., Hokkanen, J., Mattila, S., & Laine, K. (2008). The effect of oral contraceptives on the pharmacokinetics of melatonin in healthy subjects with CYP1A2 g.-163C > A polymorphism. Journal of Clinical Pharmacology, 48(8), 986–994. doi:10.​1177/​0091270008318669​.CrossRefPubMed
go back to reference Joshi, G., Wozniak, J., Petty, C., Martelon, M. K., Fried, R., Bolfek, A., et al. (2013). Psychiatric comorbidity and functioning in a clinically referred population of adults with autism spectrum disorders: A comparative study. Journal of Autism and Developmental Disorders, 43(6), 1314–1325. doi:10.1007/s10803-012-1679-5.CrossRefPubMed Joshi, G., Wozniak, J., Petty, C., Martelon, M. K., Fried, R., Bolfek, A., et al. (2013). Psychiatric comorbidity and functioning in a clinically referred population of adults with autism spectrum disorders: A comparative study. Journal of Autism and Developmental Disorders, 43(6), 1314–1325. doi:10.​1007/​s10803-012-1679-5.CrossRefPubMed
go back to reference Keijzer, H., Smits, M. G., Duffy, J. F., & Curfs, L. M. (2014). Why the dim light melatonin onset (DLMO) should be measured before treatment of patients with circadian rhythm sleep disorders. Sleep Medicine Reviews, 18(4), 333–339. doi:10.1016/j.smrv.2013.12.001.CrossRefPubMed Keijzer, H., Smits, M. G., Duffy, J. F., & Curfs, L. M. (2014). Why the dim light melatonin onset (DLMO) should be measured before treatment of patients with circadian rhythm sleep disorders. Sleep Medicine Reviews, 18(4), 333–339. doi:10.​1016/​j.​smrv.​2013.​12.​001.CrossRefPubMed
go back to reference Kulman, G., Lissoni, P., Rovelli, F., Roselli, M. G., Brivio, F., & Sequeri, P. (2000). Evidence of pineal endocrine hypofunction in autistic children. Neuro Endocrinology Letters, 21(1), 31–34.PubMed Kulman, G., Lissoni, P., Rovelli, F., Roselli, M. G., Brivio, F., & Sequeri, P. (2000). Evidence of pineal endocrine hypofunction in autistic children. Neuro Endocrinology Letters, 21(1), 31–34.PubMed
go back to reference Leu, R. M., Beyderman, L., Botzolakis, E. J., Surdyka, K., Wang, L., & Malow, B. A. (2011). Relation of melatonin to sleep architecture in children with autism. [Research Support, Non-U.S. Gov’t]. Journal of Autism and Developmental Disorders, 41(4), 427–433, doi:10.1007/s10803-010-1072-1.CrossRefPubMedPubMedCentral Leu, R. M., Beyderman, L., Botzolakis, E. J., Surdyka, K., Wang, L., & Malow, B. A. (2011). Relation of melatonin to sleep architecture in children with autism. [Research Support, Non-U.S. Gov’t]. Journal of Autism and Developmental Disorders, 41(4), 427–433, doi:10.​1007/​s10803-010-1072-1.CrossRefPubMedPubMedCentral
go back to reference Lord, C., Rutter, M., DiLavore, P. C., Risi, S., Gotham, K., & Bishop, S. L. (2012). Autism Diagnostic Observation Schedule (2nd edn.). Los Angeles, CA: Western Psychological Services. Lord, C., Rutter, M., DiLavore, P. C., Risi, S., Gotham, K., & Bishop, S. L. (2012). Autism Diagnostic Observation Schedule (2nd edn.). Los Angeles, CA: Western Psychological Services.
go back to reference Malow, B., Adkins, K. W., McGrew, S. G., Wang, L., Goldman, S. E., Fawkes, D., et al. (2012). Melatonin for sleep in children with autism: a controlled trial examining dose, tolerability, and outcomes. Journal of Autism and Developmental Disorders, 42(8), 1729–1737. doi:10.1007/s10803-011-1418-3.CrossRefPubMedPubMedCentral Malow, B., Adkins, K. W., McGrew, S. G., Wang, L., Goldman, S. E., Fawkes, D., et al. (2012). Melatonin for sleep in children with autism: a controlled trial examining dose, tolerability, and outcomes. Journal of Autism and Developmental Disorders, 42(8), 1729–1737. doi:10.​1007/​s10803-011-1418-3.CrossRefPubMedPubMedCentral
go back to reference Nadeau, J. M., Arnold, E. B., Keene, A. C., Collier, A. B., Lewin, A. B., Murphy, T. K., & Storch, E. A. (2015). Frequency and clinical correlates of sleep-related problems among anxious youth with autism sepctrum disorders. Child Psychiatry and Human Development, 46, 558–566. doi:10.1007/s10578-014-0496-9.CrossRefPubMed Nadeau, J. M., Arnold, E. B., Keene, A. C., Collier, A. B., Lewin, A. B., Murphy, T. K., & Storch, E. A. (2015). Frequency and clinical correlates of sleep-related problems among anxious youth with autism sepctrum disorders. Child Psychiatry and Human Development, 46, 558–566. doi:10.​1007/​s10578-014-0496-9.CrossRefPubMed
go back to reference Nir, I., Meir, D., Zilber, N., Knobler, H., Hadjez, J., & Lerner, Y. (1995). Brief report: Circadian melatonin, thyroid-stimulating hormone, prolactin, and cortisol levels in serum of young adults with autism. Journal of Autism and Developmental Disorders, 25(6), 641–654.CrossRefPubMed Nir, I., Meir, D., Zilber, N., Knobler, H., Hadjez, J., & Lerner, Y. (1995). Brief report: Circadian melatonin, thyroid-stimulating hormone, prolactin, and cortisol levels in serum of young adults with autism. Journal of Autism and Developmental Disorders, 25(6), 641–654.CrossRefPubMed
go back to reference Pandi-Perumal, S. R., Smits, M., Spence, W., Srinivasan, V., Cardinali, D. P., Lowe, A. D., et al. (2007a). Dim light melatonin onset (DLMO): a tool for the analysis of circadian phase in human sleep and chronobiological disorders. Progress in Neuropsychopharmacology & Biological Psychiatry, 31(1), 1–11. doi:10.1016/j.pnpbp.2006.06.020.CrossRef Pandi-Perumal, S. R., Smits, M., Spence, W., Srinivasan, V., Cardinali, D. P., Lowe, A. D., et al. (2007a). Dim light melatonin onset (DLMO): a tool for the analysis of circadian phase in human sleep and chronobiological disorders. Progress in Neuropsychopharmacology & Biological Psychiatry, 31(1), 1–11. doi:10.​1016/​j.​pnpbp.​2006.​06.​020.CrossRef
go back to reference Pandi-Perumal, S. R., Srinivasan, V., Spence, D. W., & Cardinali, D. P. (2007b). Role of the melatonin system in the control of sleep: Therapeutic implications. CNS Drugs, 21(12), 995–1018.CrossRefPubMed Pandi-Perumal, S. R., Srinivasan, V., Spence, D. W., & Cardinali, D. P. (2007b). Role of the melatonin system in the control of sleep: Therapeutic implications. CNS Drugs, 21(12), 995–1018.CrossRefPubMed
go back to reference Papp, M., Litwa, E., Gruca, P., & Mocaer, E. (2006). Anxiolytic-like activity of agomelatine and melatonin in three animal models of anxiety. Behavioural Pharmacology, 17(1), 9–18.PubMed Papp, M., Litwa, E., Gruca, P., & Mocaer, E. (2006). Anxiolytic-like activity of agomelatine and melatonin in three animal models of anxiety. Behavioural Pharmacology, 17(1), 9–18.PubMed
go back to reference Patzold, L. M., Richdale, A. L., & Tonge, B. J. (1998). An investigation into sleep characteristics of children with autism and Asperger’s disorder. Journal of Paediatrics and Child Health, 34, 528–533.CrossRefPubMed Patzold, L. M., Richdale, A. L., & Tonge, B. J. (1998). An investigation into sleep characteristics of children with autism and Asperger’s disorder. Journal of Paediatrics and Child Health, 34, 528–533.CrossRefPubMed
go back to reference Richdale, A. L. (1999). Sleep problems in autism: Prevalence, cause, and intervention. Developmental Medicine and Child Neurology, 41, 60–66.CrossRefPubMed Richdale, A. L. (1999). Sleep problems in autism: Prevalence, cause, and intervention. Developmental Medicine and Child Neurology, 41, 60–66.CrossRefPubMed
go back to reference Richdale, A. L., & Schreck, K. A. (2009). Sleep problems in autism spectrum disorders: Prevalence, nature & possible biopsychosocial aetiologies. Sleep Medicine Reviews, 13(6), 403–411.CrossRefPubMed Richdale, A. L., & Schreck, K. A. (2009). Sleep problems in autism spectrum disorders: Prevalence, nature & possible biopsychosocial aetiologies. Sleep Medicine Reviews, 13(6), 403–411.CrossRefPubMed
go back to reference Ritvo, E., Ritvo, R., Yuwiler, A., Brothers, A., Freeman, B., & Plotkin, S. (1993). Elevated daytime melatonin concentrations in autism: A pilot study. European Child & Adolescent Psychiatry, 2(2), 75–78. doi:10.1007/bf02098862.CrossRef Ritvo, E., Ritvo, R., Yuwiler, A., Brothers, A., Freeman, B., & Plotkin, S. (1993). Elevated daytime melatonin concentrations in autism: A pilot study. European Child & Adolescent Psychiatry, 2(2), 75–78. doi:10.​1007/​bf02098862.CrossRef
go back to reference Robillard, R., Naismith, S. L., Rogers, N. L., Scott, E. M., Ip, T. K., Hermens, D. F., et al. (2013). Sleep-wake cycle and melatonin rhythms in adolescents and young adults with mood disorders: comparison of unipolar and bipolar phenotypes. European Psychiatry, 28(7), 412–416. doi:10.1016/j.eurpsy.2013.04.001.CrossRefPubMed Robillard, R., Naismith, S. L., Rogers, N. L., Scott, E. M., Ip, T. K., Hermens, D. F., et al. (2013). Sleep-wake cycle and melatonin rhythms in adolescents and young adults with mood disorders: comparison of unipolar and bipolar phenotypes. European Psychiatry, 28(7), 412–416. doi:10.​1016/​j.​eurpsy.​2013.​04.​001.CrossRefPubMed
go back to reference Salti, R., Galluzzi, F., Bindi, G., Perfetto, F., Tarquini, R., Halberg, F., et al. (2000). Nocturnal melatonin patterns in children. Journal of Clinical Endocrinology and Metabolism, 85, 2137–2144.CrossRefPubMed Salti, R., Galluzzi, F., Bindi, G., Perfetto, F., Tarquini, R., Halberg, F., et al. (2000). Nocturnal melatonin patterns in children. Journal of Clinical Endocrinology and Metabolism, 85, 2137–2144.CrossRefPubMed
go back to reference Spielberger, C. D., Gorsuch, R. L., Lushene, R., Vagg, P. R., & Jacobs, G. A. (1983). Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press. Spielberger, C. D., Gorsuch, R. L., Lushene, R., Vagg, P. R., & Jacobs, G. A. (1983). Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press.
go back to reference Tordjman, S., Anderson, G. M., Bellissant, E., Botbol, M., Charbuy, H., Camus, F., … Touitou, Y. (2012). Day and nighttime excretion of 6-sulphatoxymelatonin in adolescents and young adults with autistic disorder. Psychoneuroendocrinology, 37, 1990–1997. doi:10.1016/j.psyneuen.2012.04.013.CrossRefPubMed Tordjman, S., Anderson, G. M., Bellissant, E., Botbol, M., Charbuy, H., Camus, F., … Touitou, Y. (2012). Day and nighttime excretion of 6-sulphatoxymelatonin in adolescents and young adults with autistic disorder. Psychoneuroendocrinology, 37, 1990–1997. doi:10.​1016/​j.​psyneuen.​2012.​04.​013.CrossRefPubMed
go back to reference Tsaousis, I. (2010). Circadian preferences and personality traits: A meta-analysis. European Journal of Personality, 24(4), 356–373. doi:10.1002/per.754. Tsaousis, I. (2010). Circadian preferences and personality traits: A meta-analysis. European Journal of Personality, 24(4), 356–373. doi:10.​1002/​per.​754.
go back to reference von Bahr, C., Ursing, C., Yasui, N., Tybring, G., Bertilsson, L., & Röjdmark, S. (2000). Fluvoxamine but not citalopram increases serum melatonin in healthy subjects—an indication that cytochrome P 450 CYP1A2 and CYP2C19 hydroxylate melatonin. European Journal of Clinical Pharmacology, 56(2), 123–127. doi:10.1007/s002280050729.CrossRef von Bahr, C., Ursing, C., Yasui, N., Tybring, G., Bertilsson, L., & Röjdmark, S. (2000). Fluvoxamine but not citalopram increases serum melatonin in healthy subjects—an indication that cytochrome P 450 CYP1A2 and CYP2C19 hydroxylate melatonin. European Journal of Clinical Pharmacology, 56(2), 123–127. doi:10.​1007/​s002280050729.CrossRef
go back to reference Voultsios, A., Kennaway, D. J., & Dawson, D. (1997). Salivary melatonin as a circadian phase marker: Validation and comparison to plasma melatonin. Journal of Biological Rhythms, 12(5), 457–466.CrossRefPubMed Voultsios, A., Kennaway, D. J., & Dawson, D. (1997). Salivary melatonin as a circadian phase marker: Validation and comparison to plasma melatonin. Journal of Biological Rhythms, 12(5), 457–466.CrossRefPubMed
go back to reference Wasdell, M. B., Jan, J. E., Bomben, M. M., Freeman, R. D., Rietveld, W. J., Tai, J., et al. (2008). A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities. Journal of Pineal Research, 44, 57–64. doi:10.1111/j.1600-079X.2007.00528.x.PubMed Wasdell, M. B., Jan, J. E., Bomben, M. M., Freeman, R. D., Rietveld, W. J., Tai, J., et al. (2008). A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities. Journal of Pineal Research, 44, 57–64. doi:10.​1111/​j.​1600-079X.​2007.​00528.​x.PubMed
go back to reference Wechsler, D. (1999). WASI Administration and Scoring Manual. San Antonio, TX: The Psychological Corporation. Wechsler, D. (1999). WASI Administration and Scoring Manual. San Antonio, TX: The Psychological Corporation.
go back to reference Wechsler, D. (2008). WAIS-IV Administration and Scoring Manual. San Antonio, TX: The Psychological Corporation. Wechsler, D. (2008). WAIS-IV Administration and Scoring Manual. San Antonio, TX: The Psychological Corporation.
go back to reference Wiggs, L., & Stores, G. (2004). Sleep patterns and sleep disorders in children with autistic spectrum disorders: Insights using parent report and actigraphy. Developmental Medicine & Child Neurology, 46(6), 372–380. doi:10.1017/S0012162204000611. Wiggs, L., & Stores, G. (2004). Sleep patterns and sleep disorders in children with autistic spectrum disorders: Insights using parent report and actigraphy. Developmental Medicine & Child Neurology, 46(6), 372–380. doi:10.​1017/​S001216220400061​1.
go back to reference Woodbury-Smith, M. R., Robinson, J., Wheelwright, S., & Baron-Cohen, S. (2005). Screening adults for Asperger Syndrome using the AQ: A preliminary study of its diagnostic validity in clinical practice. Journal of Autism and Developmental Disorders, 35(3), 331–335.CrossRefPubMed Woodbury-Smith, M. R., Robinson, J., Wheelwright, S., & Baron-Cohen, S. (2005). Screening adults for Asperger Syndrome using the AQ: A preliminary study of its diagnostic validity in clinical practice. Journal of Autism and Developmental Disorders, 35(3), 331–335.CrossRefPubMed
go back to reference Zawilska, J. B., Skene, D. J., & Arendt, J. (2009). Physiology and pharmacology of melatonin in relation to biological rhythms. Pharmacological Reports, 61(3), 383–410.CrossRefPubMed Zawilska, J. B., Skene, D. J., & Arendt, J. (2009). Physiology and pharmacology of melatonin in relation to biological rhythms. Pharmacological Reports, 61(3), 383–410.CrossRefPubMed
Metagegevens
Titel
Assessing the Dim Light Melatonin Onset in Adults with Autism Spectrum Disorder and No Comorbid Intellectual Disability
Auteurs
Emma K. Baker
Amanda L. Richdale
Agnes Hazi
Luke A. Prendergast
Publicatiedatum
26-04-2017
Uitgeverij
Springer US
Gepubliceerd in
Journal of Autism and Developmental Disorders / Uitgave 7/2017
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI
https://doi.org/10.1007/s10803-017-3122-4

Andere artikelen Uitgave 7/2017

Journal of Autism and Developmental Disorders 7/2017 Naar de uitgave